Hypercalcemia and metastatic calcification

Cardiovascular Research

Volumn 36, Issue 3, 1997, Pages 293-297

  Kerr, D N S ^a  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

Calcinosis; Calciphylaxis; Chronic renal failure; Hypercalcemia; Milk alkali syndrome; Vitamin D toxicity

Indexed keywords

CALCIUM; ERGOCALCIFEROL; PHOSPHATE; VITAMIN D;

BLOOD VESSEL CALCIFICATION; CALCINOSIS; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DRUG OVERDOSE; GRANULOMATOSIS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; IATROGENIC DISEASE; LUNG CALCIFICATION; OSTEODYSTROPHY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; RICKETS; SARCOIDOSIS; VITAMIN D INTOXICATION;

CALCINOSIS; CALCIPHYLAXIS; CARDIOMYOPATHIES; CORONARY DISEASE; HUMANS; HYPERCALCEMIA; KIDNEY FAILURE, CHRONIC; LUNG DISEASES; VASCULAR DISEASES; VITAMIN D;

EID: 0031456405     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00243-5     Document Type: Review

References (49)

1. Chaplis H., Clark L.D., Ropes M.W. Vitamin D intoxication. Am J Med Sci. 221:1951;369-378.
2. Christensen W.R., Liebman C., Sosman M.C. Skeletal and periarticular manifestations of hypervitaminosis D. Am J Roentgenol. 65:1951;27-39.
3. Holman C.B. Roentgenologic manifestations of vitamin D intoxication. Radiology. 59:1952;805-816.
4. Davies M.D., Mawer E.B., Freemont A.J. The osteodystrophy of hypervitaminosis D: a metabolic study. Q J Med. 61:1986;911-919.
5. Kanis J.A., Russell R.G.G. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1α-hydroxylated derivatives. Br Med J. 1:1977;78.
6. Butler R.C., Dieppe P.A., Keat A.C.S. Calcinosis of joints and periarticular tissues associated with vitamin D intoxication. Ann Rheum Dis. 44:1985;494-498.
7. Sato K., Emoto N., Toraya S., Tsushima T., Demura H., Tsuji N., Inaba S., Takeuchi A., Kobayashi T. Progressively increased 1,25-dihydroxyvitamin D2 concentration in a hypoparathyroid patient with protracted hypercalcemia due to vitamin D2. Endocrine J. 41:1994;329-337.
8. Davies M., Adams P.H. The continuing risk of vitamin D intoxication. Lancet. ii:1978;621-623.
9. Paterson C.R. Vitamin-D poisoning: survey of causes in 21 patients with hypercalcaemia. Lancet. i:1980;1164-1165.
10. Verge C.F., Lam A., Simpson J.M., Cowell C.T., Howard N.J. Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. 325:1991;1843-1848.
11. British Paediatric Association Infantile hypercalcaemia, nutritional rickets and infantile scurvy in Britain. Br Med J. 1:1964;1659-1661.
12. Weber K.T. Huldre folk of Elfame: a case of hidden infirmities. Cardiovascular Research. 36:1997;132-133.
13. Jacobus C.H., Holick M.F., Shao Q., Chen T.C., Holm I.A., Kolodny J.M., Fuleihan G.E.-H., Seely E.W. Hypervitaminosis D associated with drinking milk. N Engl J Med. 326:1992;1173-1177.
14. Blank S.B., Scanlon K.S., Sinks T.H., Lett S., Falk H. An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. Am J Public Health. 85:1995;656-659.
15. Chen T.C., Heath H., Holick M.F. An update on the vitamin D-content of fortified milk from the United States and Canada. N Engl J Med. 329:1993;1507.
16. Holick M.F., Shao Q., Liu W.W., Chen T.C. The vitamin D content of fortified milk and infant formula. N Engl J Med. 326:1992;1178-1181.
17. McKenna M.J., Freaney R., Byrne P., McBrinn Y., Murray B., Kelly M., Donne B., O'Brien M. Safety and efficacy of increasing wintertime vitamin D and calcium intake by milk fortification. Q J Med. 88:1995;895-898.
18. Shaker J.L., Redlin K.C., Warren G.V., Findling J.W. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis. Am J Med Sci. 308:1994;115-118.
19. Spindel S.J., Hamill R.J., Georghiou P.R., Lacke C.E., Green L.K., Mallette L.E. Case report: vitamin D-mediated hypercalcemia in fungal infections. Am J Med Sci. 310:1995;71-76.
20. Hardt I.J., Rivers A.B. Toxic manifestations following the alkaline treatment of peptic ulcer. Arch Intern Med. 31:1923;171-180.
21. Beall D.P., Scofield R.H. Milk-alkali syndrome: Associated with calcium carbonate consumption. Medicine. 74:1995;89-96.
22. Weinreich T., Passlick-Deetjen J., Ritz E. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Am J Kidney Dis. 25:1995;452-460.
23. Parsons V., Baldwin D., Moniz C., Marsden J., Ball E., Rifkin I. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders. Nephron. 63:1993;379-383.
24. Chertow G.M., Burke S.V., Lazarus J.M., Stenzel K.H., Wombolt D., Goldberg D., Bonventre J.V., Slatopolsky E. Poly[allylamine Hydrochloride] (RenaGel). A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis. 29:1997;66-71.
25. H. Selye, Calciphylaxis. University of Chicago Press. Chicago. 1962.
26. Edelstein C.L., Wickham M.K., Kirby P.A. Systemic calciphylaxis presenting as a painful, proximal myopathy. Postgrad Med J. 68:1992;209-211.
27. Lugo-Somolinos A., Sánchez J.L., Méndez-Coll J., Joglar F. Calcifying panniculitis associated with polycystic kidney disease and chronic renal failure. J Am Acad Dermatol. 22:1990;743-747.
28. Ross C.N., Cassidy M.J.D., Thompson M., Russell-Jones R., Rees A.J. Proximal cutaneous necrosis associated with small vessel calcification in renal failure. Q J Med. 79:1991;443-450.
29. Wilkinson S.P., Stewart W.K., Parham D.M., Guthrie W. Symmetric gangrene of the extremities in late renal failure: a case report and review of the literature. Q J Med. 67:1988;319-341.
30. Fischer A.H., Morris D.J. Pathogenesis of calciphylaxis. Study of three cases and review of the literature. Human Pathology. 26:1995;1055-1064.
31. Pan D., Hsu K., Ray S.C. Ecchymoses and eschars at sites of injection. Lancet. 349:1997;1364.
32. Hafner J., Keusch G., Wahl C., Sauter B., Hürlimann A., von Weizsäcker F., Krayenbühl M., Biedermann K., Brunner U., Helfenstein U., Burg G. Uremic small-artery disease with medial calcification and intimal hyperplasia (so called calciphylaxis): A complication of chronic renal failure and benefit from parathyroidectomy. Am J Dermatol. 33:1995;954-962.
33. Malberti F., Corradi B., Cosci P., Calliada F., Marcelli D., Imbasciati E. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism. Am J Kidney Dis. 28:1996;704-712.
34. 2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Am J Kidney Dis. 26:1995;852-860.
35. Cassidy M.J.D., Owen J.P., Ellis H.A., Dewar J., Robinson C.J., Wilkinson R., Ward M.K., Kerr D.N.S. Renal osteodystrophy and metastatic calcification in long-term continuous ambulatory peritoneal dialysis. Q J Med. 54:1985;29-48.
36. Yokoyama K. Study of vascular calcification in patients on continuous ambulatory peritoneal dialysis: special reference to vitamin D treatment. Jap J Nephrol. 35:1993;1171-1180.
37. Hüting J. Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease in peritoneal dialysis. Chest. 105:1994;383-388.
38. D'Cruz I.A., Madu E.C. Progression to calcific mitral stenosis in end stage renal disease. Am J Kidney Dis. 26:1996;956-959.
39. Maher E.R., Young G., Smyth-Walsh B., Pugh S., Curtis J.R. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet. ii:1987;875-877.
40. Straumann E., Meye B., Miteli M., Blumberg A., Jenzer H.R. Aortic and mitral valve disease in patients with end stage renal failure on long term haemodialysis. Br Heart J. 67:1192;236-239.
41. Fulladosa X., González M.T., Cruzado J.M., Andrés E., Castelao A.M., Griñò J.M., Alsina J. Metastatic pulmonary calcifications in severe secondary hyperparathyroidism: evolution after renal transplantation. Transplant Proc. 27:1995;2272-2276.
42. Milliner D.S., Lieberman E., Landing B.H. Pulmonary calcinosis after renal transplantation in pediatric patients. Am J Kidney Dis. 7:1986;495-501.
43. Hartman T.E., Müller N.L., Primack S.L., Jonkoh T., Takeuchi N., Ikezoe J., Swenses S.J. Metastatic pulmonary calcification in patients with hypercalcemia: findings on chest radiographs and CT scans. Am J Roentgenol. 162:1994;799-802.
44. Conger J.D., Hammond W.S., Alfrey A.C., Contiguglia S.R., Stanford R.E., Huffer W.E. Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. Ann Intern Med. 83:1975;330-336.
45. Fitzpatrick L.A., Severson A., Edwards W.D., Ingram R.T. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest. 94:1994;1597-1604.
46. Shen M., Marie P., Farge D., Carpentier S., de Pollak C., Hott M., Chen L., Martinet B., Carpentier A. Osteopontin is associated with bioprosthetic heart valve calcification in humans. CR Acad Sci Paris Life Sciences. 320:1997;49-57.
47. Bellahcène A., Castronov V. Increased expression of osteonectin and osteopontin, two bone matrix proteins in human breast cancer. Am J Pathol. 146:1995;95-100.
48. Srivatsa S.S., Harrity P.J., Maercklein P.B., Kleppe L., Veinot J., Edwards W.D., Johnson C.M., Fitzpatrick L.A. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest. 99:1997;996-1009.
49. Shanahan C.M., Cary N.R.B., Metcalfe J.C., Weiseberg P.L. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 93:1994;2393-2402.